XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.25.3

Stock Options and Warrants | 9 Months Ended
--- | ---
Sep. 30, 2025
Stock Options and Warrants [Abstract] |
STOCK OPTIONS AND WARRANTS | 13. STOCK OPTIONS AND WARRANTS Stock Options The Company has not granted any options during the nine months ended September 30, 2025 and 2024. The Company’s most recent option grant was in 2022 that 76,190 shares (post-split) of common stock were granted to employees and certain consultants. The weighted average grant date fair value of options granted in 2022 was $27.9 (post-split). There are 386,021 options available for grant under the 2016 Equity Incentive Plan as of December 31, 2024. Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair values of these options over vesting period. As of September 30, 2025 and December 31, 2024, there were no unvested options. Options issued and outstanding as of September 30, 2025, and their activities during the period then ended are as follows:
|  |  |  |  | Weighted- |  |  | Weighted- |  |  |  |
|  |  |  |  | Average |  |  | Average |  |  |  |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  |  |
|  | Underlying Shares (post-split) |  |  | Price Per Share (post-split) |  |  | Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.74 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding as of September 30, 2025 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 6.00 |  |  | $ | - |
Exercisable as of September 30, 2025 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 6.00 |  |  | $ | - |
Vested and expected to vest |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.00 |  |  | $ | - |
Stock Warrants Warrants issued and outstanding in connection with Shuling land transaction (See Note 5) as of September 30, 2025, and their activities during the nine-month period ended are as follows:
|  | Number of Underlying Shares |  |  | Weighted- Average Exercise Price Per Share |  |  | Weighted- Average Contractual Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Issued |  |  | 1,000,000 |  |  |  | 2.50 |  |  |  | 5.00 |  |  |  | - |
Exercised |  |  | - |  |  | $ | - |  |  |  | - |  |  |  | - |
Outstanding as of September 30, 2025 |  |  | 1,000,000 |  |  | $ | 2.50 |  |  |  | 4.79 |  |  | $ | 540,000 |
Warrants issued and outstanding in connection with Lind convertible notes (See Note 12) as of September 30, 2025, and their activities during the nine-month period ended are as follows:
|  | Number of Underlying Shares |  |  | Weighted- Average Exercise Price Per Share |  |  | Weighted- Average Contractual Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | 2,029,167 |  |  | $ | 0.40 | * |  |  | 4.20 |  |  | $ | 195,542 |
Issued |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (1,529,167 | ) |  | $ | 0.60 |  |  |  | - |  |  |  | - |
Outstanding as of September 30, 2025 |  |  | 500,000 |  |  | $ | 1.00 |  |  |  | 3.64 |  |  | $ | 1,020,000 |
* | On January 5, 2025, the Company and Lind entered into a third letter agreement (the “December Letter Agreement”), pursuant to which Lind agreed to exercise for cash, 1,029,167 of the Existing Warrants to purchase shares of Common Stock, with a current exercise price of $0.75 per share, at a reduced exercise price of $0.40 per share. The weighted average exercise price per share as of December 31, 2024 was adjusted to the reduction accordingly.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration